Maplelane Capital’s Oracle ORCL Stock Holding History

Maplelane Capital’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,500,000	Closed	-$85.5M	–	158
2019 Q2	$85.5M	Buy	+1,500,000	New	+$81.2M	1.81%	14
2018 Q1	–	Sell	-425,000	Closed	-$20.1M	–	165
2017 Q4	$20.1M	Buy	+425,000	New	+$20.8M	0.44%	56
2017 Q3	–	Sell	-3,500	Closed	-$17.5M	–	172
2017 Q2	$17.5M	Buy	+3,500	New	+$160K	0.32%	52

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Maplelane Capital's ORCL Position: Q4 2023 in Review

Maplelane Capital sold out of Oracle (ORCL) in Q4 2023, closing a stake of 100,000 shares — an estimated $10.6M sold.

Maplelane Capital first reported a position in ORCL in Q2 2017 and held it in 3 quarters. The position peaked at $20.1M in Q4 2017. 2,694 funds tracked by Wall St. Rank hold ORCL as of Q4 2023.

Maplelane Capital reported no remaining Oracle position as of Q4 2023 after selling out during the quarter.
Maplelane Capital sold 100,000 Oracle shares in Q4 2023, an estimated $10.6M.
Maplelane Capital first reported a position in Oracle in Q2 2017 and held it in 3 quarters.
Maplelane Capital's Oracle position peaked at $20.1M in Q4 2017.
2,694 funds tracked by Wall St. Rank held Oracle as of Q4 2023.

Based on Maplelane Capital's 13F filing for Q4 2023, filed 14 Feb 2024.